CERS

Cerus Corporation

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$1.94

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %17.6 / %30

Non-compliant assets / Total market cap %11.9 / %30

Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.

Website

Analysis (Turkish): CERS Hissesi Caiz mi, Helal mi? Cerus Corporation Katılım Analizi